Xyall raises €5.0M Series A round
13 January 2020· Eindhoven, The Netherlands· health, diagnostics, robotics, ai, b2b, software_hardware
The investment was intended to fast track the development, manufacture and commercialization of a fully automated, high-precision tumor tissue dissection solution for global molecular pathology laboratories.
Investors
LeadSioux Technologies
Also participating
BOM Brabant VenturesNetherlands Enterprise Agency
About Xyall
Stage
Series C
Headquarters
Eindhoven, The Netherlands
Founded
2018
Team Size
21–50
Sectors
healthdiagnosticsroboticsaib2bsoftware_hardware